开发阿联的孤儿药物多标准决策分析工具
Khalid A Alnaqbi1,2, Baher Elezbawy3,4, Ahmad N Fasseeh5,6
1Internal Medicine, College of Medicine & Health Sciences, United Arab Emirates University, Al Ain, ARE.
Cureus
|April 1, 2024
概括
一个新的多标准决策分析 (MCDA) 工具评估阿联的孤儿药物,指导退款决策. 该工具促进了对罕见疾病的基于价值的医疗保健.
科学领域:
- 卫生经济学 卫生经济学
- 制药政策 制药政策
- 罕见疾病 罕见疾病
背景情况:
- 全球孤儿药批准的增加给医疗保健系统带来了重大的财务挑战.
- 阿拉伯联合长国 (阿联) 需要一个结构化的方法来评估孤儿药物,以获得补偿和采购.
- 现有的评估框架可能无法充分解决阿联的独特背景.
研究的目的:
- 开发和验证一个多标准决策分析 (MCDA) 工具,用于评估阿联的孤儿药物.
- 为有关孤儿药物的报销和采购决策提供基于证据的指导.
- 在阿联内支持基于价值的罕见疾病医疗保健计划.
主要方法:
- 文献审查和专家采访以确定初步评估标准.
- 与阿联医疗保健专家和决策者举行共识建设会议,以改进和排名标准.
- 在Microsoft Excel中开发阿联MCDA工具,结合专家定义的权重和评分功能.
- 工具的验证和测试,使用现实世界的案例研究.
主要成果:
- 为阿联成功开发了一种针对孤儿药物的验证的MCDA工具.
- 十个关键标准被纳入该工具,分配的权重反映了它们的重要性.
- 成本效益 (25.1%),健康益处的大小 (20.1%) 和治疗替代品的可用性 (14.3%) 是权重最高的标准.
- 其他包括的标准包括疾病严重程度,预算影响,疾病罕见性,临床证据强度,家庭负担,指示独特性和患者年龄.
结论:
- 实施基于证据的医疗保健需要评估健康技术的公允价值,包括孤儿药物.
- 开发的阿联MCDA工具可以帮助决策者做出基于价值和证据的报销决定.
- 该工具支持阿联解决未满足的医疗需求和改善罕见病患者护理的优先事项.
相关概念视频
01:12Analysis of Population Pharmacokinetic Data
254
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
254
01:02Prescription, Nonprescription and Orphan Drugs
725
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
725
01:26Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
01:28Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
01:28Structure-Activity Relationships and Drug Design
716
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
716
01:11Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K